XML 57 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash Flows from Operating Activities:      
Net (loss) income $ (247,859) $ (179,789) $ 23,980
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 56,493 59,057 62,373
Deferred income tax (benefit) expense (27,156) (32,593) (4,315)
Provision for doubtful accounts 1,401 203 178
Share-based compensation 15,628 20,156 18,006
Capitalized software write-off     6,091
Non-cash restructuring charges, net 548 2,480 1,461
Goodwill and other asset impairment 274,285 229,317 5,375
Changes in operating assets and liabilities:      
Cash restricted or segregated under regulations and other 11,700 (2,625) 25,843
Deposits with clearing organizations (3,611) (11,303) 656
Securities owned, at fair value (4,689) 18,403 (18,058)
Receivables from brokers, dealers and clearing organizations (230,137) (6,671) (503,140)
Receivables from customers (59,252) 134,913 (290,031)
Accounts payable and accrued expenses (22,905) (18,079) (31,995)
Payables to brokers, dealers and clearing organizations 241,231 (59,605) 889,457
Payables to customers 15,595 (64,592) (37,698)
Securities sold, not yet purchased, at fair value 4,695 (18,915) 18,347
Income taxes receivable/payable (1,459) (6,053) 10,446
Other, net 2,284 2,755 (867)
Net cash provided by operating activities 26,792 67,059 176,109
Cash Flows from Investing Activities:      
Acquisition of subsidiaries and minority interests, net of cash acquired   (36,185) (48,926)
Capital purchases (33,424) (22,857) (19,280)
Capitalization of software development costs (24,635) (29,061) (33,897)
Proceeds from sale of investments   2,095  
Net cash used in investing activities (58,059) (86,008) (102,103)
Cash Flows from Financing Activities:      
Proceeds of short-term bank loans 20,548 1,606  
Proceeds from term loans   25,469  
Repayments of term loans (7,185) (4,043) (46,900)
Proceeds from interim funding facility 605    
Proceeds from sales-lease back transactions 1,855 2,571  
Debt issuance costs   (2,908)  
Common stock issued 2,674 9,753 10,896
Common stock repurchased (23,457) (38,928) (50,284)
Shares withheld for net settlements of share-based awards (2,817) (5,984) (4,095)
Net cash used in financing activities (7,777) (12,464) (90,383)
Effect of exchange rate changes on cash and cash equivalents 731 (1,409) 2,508
Net decrease in cash and cash equivalents (38,313) (32,822) (13,869)
Cash and cash equivalents-beginning of year 284,188 317,010 330,879
Cash and cash equivalents-end of year 245,875 284,188 317,010
Supplemental cash flow information:      
Interest paid 2,673 2,453 1,343
Income taxes paid 5,495 15,508 19,345
Majestic acquisition replacement awards     $ 2,994